...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,1 Oa-Octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole],a Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Anorectic Activity
【24h】

WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,1 Oa-Octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole],a Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Anorectic Activity

机译:WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,1 Oa-八氢-7bH-环戊烯-[b] [1,4]二氮杂p [6,7,1hi]吲哚],具有厌食活性的新型5-羟色胺2C受体选择性激动剂

获取原文
获取原文并翻译 | 示例

摘要

The pharmacological profile of WAY-163909 [(7bR,-10aR)-1,2,3,4,8,9,10,1 Oa-octahydro-7bH-cyclopenta-[b][1,4]diaze-pino[6,7,1hi]indole],a novel 5-hydroxytryptamine (HT)_(2C) (serotonin) receptor-selective agonist is presented.WAY-163909 displaced [~(125)l]2,5-dimethoxy-4-iodoamphetamine binding from human 5-HT_(2C) receptor sites,in Chinese hamster ovary (CHO) cell membranes,with a K_i value of 10.5 +- 1.1 nM.Binding affinities determined for the human 5-HT_(2A_ and 5-HT_(2B) receptor subtypes were 212 and 485 nM,respectively.In functional studies,WAY-163909 stimulated the mobilization of in-tracellular calcium in CHO cells stably expressing the human 5-HT_(2C) receptor with an EC_(50) value of 8 nM,and E_(max) relative to 5-HT of 90%.WAY-163909 failed to stimulate calcium mobilization in cells expressing the human 5-HT_(2A) receptor subtype (EC_(50)10 muM) and was a 5-HT_(2B) receptor partial agonist (EC_(50) 185 nM,Emax 40%).WAY-163909 exhibited negligible affinity (<50% inhibition at 1 muM) for other receptor sites examined,including human 5-HT_(1A),D2,and D3 receptors,and the 5-HT transporter binding site in rat cortical membranes.WAY-163909 exhibited weak affinity for the human D4 (245 nM) and 5-HT_7 (343 nM) receptor subtypes and the alpha1 binding site in rat cortical membranes (665 nM).WAY-163909 produced a dose-dependent reduction in food intake in normal Sprague-Dawley rats (ED_(50) = 2.93 mg/kg),an effect blocked by a 5-HT_(2C) receptor antagonist but not by a 5-HT_(2A) or 5-HT_(2B) receptor antagonist.In addition,WAY-163909 decreased food intake in obese Zucker rats and diet-induced obese mice with ED_(50) values of 1.4 and 5.19 mg/kg i.p.,respectively,consistent with the potential utility of 5-HT_(2C) receptor agonists as anti-obesity agents.
机译:WAY-163909 [(7bR,-10aR)-1,2,3,4,8,9,10,1 Oa-八氢-7bH-cyclopenta- [b] [1,4] diaze-pino [ 6,7,1hi吲哚],提出了一种新型的5-羟色胺(HT)_(2C)(血清素)受体选择性激动剂。WAY-163909取代了[〜(125)l] 2,5-二甲氧基-4-来自中国仓鼠卵巢(CHO)细胞膜中人5-HT_(2C)受体位点的碘苯丙胺结合,K_i值为10.5 +-1.1 nM。确定的与人5-HT_(2A_和5-HT_( 2B)受体亚型分别为212和485 nM。在功能研究中,WAY-163909刺激稳定表达人5-HT_(2C)受体且EC_(50)值为8的CHO细胞中细胞内钙的动员。 nM,相对于5-HT的E_(max)为90%。WAY-163909无法刺激表达人5-HT_(2A)受体亚型(EC_(50) 10 muM)的细胞中的钙动员。 5-HT_(2B)受体部分激动剂(EC_(50)185 nM,Emax 40%)。WAY-163909的亲和力可忽略不计(抑制率<50%在1μM时)检测其他受体位点,包括人5-HT_(1A),D2和D3受体以及大鼠皮膜中的5-HT转运蛋白结合位点.WAY-163909对人D4的亲和力较弱(245 nM)和5-HT_7(343 nM)受体亚型以及大鼠皮膜中的alpha1结合位点(665 nM)。WAY-163909在正常Sprague-Dawley大鼠中产生了剂量依赖性的食物摄入减少(ED_(50)= 2.93 mg / kg),该作用被5-HT_(2C)受体拮抗剂阻断,但未被5-HT_(2A)或5-HT_(2B)受体拮抗剂阻断。此外,WAY-163909减少了肥胖者的食物摄入量ED_(50)值分别为1.4和5.19 mg / kg ip的Zucker大鼠和饮食诱导的肥胖小鼠与5-HT_(2C)受体激动剂作为抗肥胖剂的潜在用途一致。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号